Lipitor Holds 45% Of Statin Market; Pfizer Alliance Revenue Tops $400 Mil.
Executive Summary
Lipitor is generating 45% of the new statin prescriptions in the U.S., Pfizer announced in its quarterly sales and earning report released April 15.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PS034009
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
PS034009
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.